Pharmabiz3h
IADVL sets Guinness World Record for receiving 9,419 pledges to raise dermatological disease awareness in 24 hours
India’s largest organization of dermatologists, the Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), marked a significant milestone by achieving the Guinness World ...
Pharmabiz3h
Ventus Therapeutics’ partner Novo Nordisk doses first participant in phase 1 clinical study for NNC6022-0001, an oral NLRP3 inhibitor
Ventus Therapeutics, Inc, a clinical-stage biopharmaceutical company utilizing its proprietary structural biology and computational chemistry platform, ReSOLVE, to develop differentiated small ...
Pharmabiz3h
UroGen Pharma highlights results of sub-analysis from first and largest real-world patient cohort review of Jelmyto for pyelocalyceal solution
UroGen Pharma Ltd, a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, highlighted the results of a sub-analysis from the first ...
Pharmabiz3h
Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463
Mediar Therapeutics, Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt fibrosis progression, announced that, following FDA clearance of its investigational new ...
Pharmabiz3h
bluebird bio completes first commercial cell collection for Lyfgenia gene therapy
bluebird bio, Inc. announced that it has completed the first commercial cell collection for Lyfgenia (lovotibeglogene autotemcel), a one-time gene therapy for the treatment of sickle cell disease in ...
Pharmabiz9h
Naprod Life Sciences successfully renews EU-GMP certification for its Palghar facility
Naprod Life Sciences successfully renews EU-GMP certification for its Palghar facility: Our Bureau, Mumbai Tuesday, May 7, 2024, 16:30 Hrs [IST] Naprod Life Sciences has announced ...
Pharmabiz11h
RedHill Biopharma’s opaganib as a therapy for Ebola virus receives Chinese patent
RedHill Biopharma’s opaganib as a therapy for Ebola virus receives Chinese patent: Tel-Aviv, Israel Tuesday, May 7, 2024, 15:00 Hrs [IST] RedHill Biopharma Ltd., a specialty bio ...
Pharmabiz12h
Calliditas announces positive topline results from phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib
Stockholm, Sweden Tuesday, May 7, 2024, 14:00 Hrs [IST] ...
Pharmabiz12h
IIHMR University has 200 healthcare start-ups from across India to come under its Saamarthya 2.O
IIHMR University has 200 healthcare start-ups from across India to come under its Saamarthya 2.O ...
Pharmabiz14h
Cipla’s Breathefree initiative works on empowerment across the care continuum this asthma awareness month in May
Cipla’s Breathefree initiative works on empowerement across the care continuum this asthma awareness month in May. The significance of effective asthma management comes into sharp focus amidst the ...
Pharmabiz14h
IRLAB receives Swedish Medical Products Agency’s nod to conduct phase I study of IRL757 to treat PD, AD & other CNS diseases
IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson's disease, announced that the Swedish Medical Products Agency has approved the initiation of a phase I ...
Pharmabiz14h
Lupin receives US FDA approval for travoprost ophthalmic solution USP
Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for travoprost ...